Mast Therapeutics, Inc. (NYSE: MSTX) provided an update regarding its recently announced campaign to evaluate strategic opportunities. Preliminary Indications of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE